Evidence map›Paper›PMID 35256309›Full record

ArticleDisability and health journal2022

Concerns on healthcare access, utilization, and safety due to COVID-19 among American adults with vision loss.

Niranjani Nagarajan, Varshini Varadaraj, Paola Chanes-Mora, L Penny Rosenblum, Bonnielin K Swenor

Open access · greenAbstract read
In one paragraph

Article in Disability and health journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Niranjani NagarajanWilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Varshini VaradarajWilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Paola Chanes-MoraAmerican Foundation for the Blind, Arlington, VA, USA.
L Penny RosenblumAmerican Foundation for the Blind, Arlington, VA, USA.
Bonnielin K SwenorWilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA; The Johns Hopkins Disability Health Research Center, Johns Hopkins University, Baltimore, MD, USA; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: bswenor@jhmi.edu.
Johns Hopkins University · USAmerican Foundation for the Blind · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLimited studies have indicated that Americans with vision loss are differentially impacted by COVID-19.

objectiveWe examined concerns with healthcare and safety among Americans with vision loss during the early phase of the pandemic (April 2020).

methodsThe Flatten Inaccessibility Survey assessed the impact of COVID-19 on healthcare (pharmacy access, maintenance of eyecare regimen, caregiver access, and resource denial) and safety (social distancing, clean surfaces, and touching public signage) concerns among Americans with low vision or who were blind. Multivariable logistic regression was used to determine associations between respondent characteristics and each concern.

resultsA total of 1921 adults responded to the survey, of whom 65% were blind and 35% had low vision. Most respondents were female (63%) and white (74%). Respondents with additional disabilities/comorbidities were more likely to report healthcare access concerns (pharmacy access, eyecare regimen, caregiver access, and ventilator access) and safety concerns (social distance, clean surfaces, and touching signage) than those with vision loss alone. In addition, females, those identifying as "other" gender, older individuals, and people with adult onset of vision impairment were more likely to experience COVID-19-related concerns and challenges related to healthcare and overall safety.

conclusionThese results suggest that while Americans with vision loss have been differentially impacted by COVID-19, adults with vision loss and additional disabilities/comorbidities are more likely to have concerns with healthcare and safety than those with vision loss alone.

Indexed as

COVID-19Persons with DisabilitiesVision, LowAdultFemaleHealth Services AccessibilityHumansMalePandemicsUnited StatesVision DisordersCOVID-19DisabilityHealthcare accessPandemicVision impairment

Identifiers

PMID35256309
PMCPMC8896742
OpenAlexW4213339681

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.